LawrenzF.SobotkaS., “Empirical Analysis of Current Approaches to Incidental Findings,”Journal of Law, Medicine & Ethics36, no. 2 (2008): 249–255.
2.
NIH, NHGRI grant # 1–R01-HG003178 (Wolf, PI).
3.
WolfS. M., “Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations,”Journal of Law, Medicine & Ethics36, no. 2 (2008): 219–248.
4.
See, e.g., FabsitzR. R., “Ethical and Practical Guidelines for Reporting Genetic Research Results to Study Participants,”Circulation: Cardiovascular Genetics3, no. 6 (2010): 574–580. For a subsequent overview, see Presidential Commission for the Study of Bioethical Issues, Anticipate and Communicate: Ethical Management of Incidental and Secondary Findings in the Clinical, Research, and Direct-to-Consumer Contexts (2013), available at <http://bioethics.gov/sites/default/files/FINALAnticipateCommunicate_PCSBI_0.pdf> (last visited August 18, 2015).
5.
WolfS. M., “Return of Individual Research Results and Incidental Findings: Facing the Challenges of Translational Science,”Annual Review of Genomics and Human Genetics14 (2013): 557–577; WolfS. M., “Incidental Findings in Neuroscience Research: A Fundamental Challenge to the Structure of Bioethics and Health Law,” in IllesJ.SahakianB. J., eds., The Oxford Handbook of Neuroethics (New York: Oxford University Press, 2011): At 623–634.
6.
NIH, NHGRI grant # 2–R01-HG003178 (Wolf, PI).
7.
WolfS. M., “Managing Incidental Findings and Research Results in Genomic Research Involving Biobanks and Archived Data Sets,”Genetics in Medicine14, no. 4 (2012): 361–384.
8.
A few forward-looking articles have begun exploring this issue. See, e.g., BattistuzziL., “Communication of Clinically Useful NGS Results to At-Risk Relatives of Deceased Research Participants: Toward Active Disclosure?”Journal of Clinical Oncology31, no. 32 (2013): 4164–4165; LolkemaM. P., “Ethical, Legal, and Counseling Challenges Surrounding the Return of Genetic Results in Oncology,”Journal of Clinical Oncology31, no. 15 (2013): 1842–1848, at 1846; ChanB., “Genomic Inheritances: Disclosing Individual Research Results From Whole-Exome Sequencing to Deceased Participants' Relatives,”American Journal of Bioethics12, no. 10 (2012): 1–8, and related commentaries in that issue; TasséA. M., “The Return of Results of Deceased Research Participants,”Journal of Law, Medicine & Ethics39, no. 4 (2011): 621–630.
9.
CSER: Clinical Sequencing Exploratory Research, available at <https://cser-consortium.org/> (last visited August 18, 2015).
10.
WolfS. M., “Returning a Research Participant's Genomic Results to Relatives: Analysis and Recommendations,”Journal of Law, Medicine & Ethics43, no. 3 (2015): 440–463.